Chen-chen Han
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Recent advances in the development of GRK2 inhibitors: blocking the interaction of GRK2 with its partners.
Journal: Acta pharmacologica Sinica
Published: December 30, 2025
Insulin-Like Growth Factor Binding Protein-2 Promotes Proliferation and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Journal: OncoTargets and therapy
Published: February 12, 2020
CP-25 inhibits PGE2-induced angiogenesis by down-regulating EP4/AC/cAMP/PKA-mediated GRK2 translocation.
Journal: Clinical science (London, England : 1979)
Published: October 06, 2019
Immunomodulatory Effects of CP-25 on Splenic T Cells of Rats with Adjuvant Arthritis.
Journal: Inflammation
Published: February 24, 2018
Is macrophage polarization important in rheumatoid arthritis?
Journal: International immunopharmacology
Published: May 17, 2017
Insulin-like growth factor-binding protein-3 inhibits IGF-1-induced proliferation of human hepatocellular carcinoma cells by controlling bFGF and PDGF autocrine/paracrine loops.
Journal: Biochemical and biophysical research communications
Published: August 04, 2016
Regulatory effects of GRK2 on GPCRs and non-GPCRs and possible use as a drug target (Review).
Journal: International journal of molecular medicine
Published: May 05, 2016
GRK2 overexpression inhibits IGF1-induced proliferation and migration of human hepatocellular carcinoma cells by downregulating EGR1.
Journal: Oncology reports
Published: November 19, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026